Family Health Centers of San Diego, INC
Family Health Centers of San Diego, INC was paid $152.45M by Medicaid between Jan 2018 and Dec 2024, across 421 billing codes. Its largest line is T1015, a visit at a community health center or clinic (one all-in rate) — 71% of everything it billed.
SAN DIEGO, CA 92113
Next to other Federally Qualified Health Center (FQHC) providers in California
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 606,112 | $19.50M | |
| 2019 | 672,982 | $18.01M | |
| 2020 | 770,760 | $21.34M | |
| 2021 | 1,082,176 | $22.70M | |
| 2022 | 1,110,964 | $18.94M | |
| 2023 | 1,277,305 | $23.48M | |
| 2024incomplete | 1,533,808 | $28.47M |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 71% | 588,381 | 426,509 | $107.63M |
| 00003 | Internal/system code - not a standard HCPCS code | 9.1% | 59,824 | 47,235 | $13.85M |
| G9012 | Other specified case management service not elsewhere classified | 4.0% | 18,887 | 15,952 | $6.08M |
| 90834 | Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient | 2.5% | 128,931 | 105,952 | $3.84M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 1.3% | 942,832 | 879,409 | $1.98M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 1.1% | 556,986 | 528,798 | $1.72M |
| 59425 | 1.1% | 61,707 | 55,165 | $1.68M | |
| 90791 | Psychiatric diagnostic evaluationPsychiatric diagnostic evaluation | 1.1% | 21,577 | 21,378 | $1.63M |
| G0467 | Community health center visit, returning patientFederally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit | <1% | 41,024 | 30,971 | $1.28M |
| G9008 | Coordinated care fee, physician coordinated care oversight services | <1% | 14,934 | 10,982 | $1.19M |
| 97139 | <1% | 91,238 | 45,524 | $1.03M | |
| 90832 | Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient | <1% | 34,353 | 30,326 | $853K |
409 more codes
| 99404 | <1% | 45,264 | $773K | |
| 59409 | Vaginal delivery only (with or without episiotomy and/or forceps) | <1% | 1,222 | $665K |
| 97161 | <1% | 17,264 | $518K | |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 9,590 | $498K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 26,534 | $443K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 189,900 | $311K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 6,493 | $254K |
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | <1% | 588 | $253K |
| 98941 | Chiropractic manipulative treatment; spinal, 3-4 regions | <1% | 26,122 | $248K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 14,969 | $234K |
| H0043 | Supported housing, per diem | <1% | 1,677 | $213K |
| V2020 | Frames, purchases | <1% | 23,386 | $203K |
| 90837 | Psychotherapy session, about an hour | <1% | 3,248 | $199K |
| 98940 | <1% | 18,616 | $173K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 55,193 | $170K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 55,270 | $170K |
| 93000 | <1% | 17,064 | $168K | |
| 92340 | Fitting of spectacles, except for aphakia; monofocal | <1% | 16,369 | $150K |
| 59514 | <1% | 295 | $140K | |
| 99460 | <1% | 2,696 | $135K | |
| 92015 | Determination of refractive state | <1% | 40,208 | $127K |
| 97803 | <1% | 86,151 | $127K | |
| 80061 | Lipid panel | <1% | 165,092 | $110K |
| 80053 | Comprehensive metabolic panel | <1% | 181,610 | $107K |
| G0470 | Federally qualified health center (fqhc) visit, mental health, established patient; a medically-necessary, face-to-face mental health encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a mental health visit | <1% | 3,184 | $106K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 122,072 | $104K |
| 76801 | <1% | 3,753 | $96K | |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | <1% | 7,010 | $90K |
| 86480 | <1% | 25,010 | $88K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 3,854 | $86K |
| 92250 | <1% | 29,002 | $84K | |
| 90677 | <1% | 4,938 | $83K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 157,093 | $81K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 20,728 | $78K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 53,066 | $74K |
| 0004A | <1% | 1,089 | $70K | |
| 87428 | <1% | 28,588 | $68K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 1,729 | $67K |
| H1001 | Prenatal care, at-risk enhanced service; antepartum management | <1% | 5,547 | $64K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 150,477 | $62K |
| 0124A | <1% | 1,086 | $61K | |
| 99401 | <1% | 21,943 | $59K | |
| 92341 | <1% | 4,577 | $56K | |
| 87536 | <1% | 5,040 | $55K | |
| 0002A | <1% | 818 | $54K | |
| 0001A | <1% | 808 | $53K | |
| 99462 | <1% | 1,985 | $52K | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 36,521 | $48K |
| H2016 | Community support for mental illness or disability, billed per day | <1% | 372 | $47K |
| 97802 | <1% | 27,127 | $45K | |
| 90651 | <1% | 11,273 | $44K | |
| 11721 | <1% | 3,756 | $43K | |
| 81002 | <1% | 91,723 | $42K | |
| G2025 | Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only | <1% | 4,485 | $42K |
| H1003 | Prenatal care, at-risk enhanced service; education | <1% | 30,327 | $39K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 1,644 | $38K |
| J7298 | Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg | <1% | 79 | $34K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 27,665 | $33K |
| 81025 | <1% | 83,587 | $32K | |
| 90739 | <1% | 4,562 | $32K | |
| 82274 | <1% | 18,925 | $31K | |
| 97810 | <1% | 2,317 | $27K | |
| 0071A | <1% | 457 | $27K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 15,057 | $25K |
| 98960 | <1% | 22,568 | $23K | |
| 92557 | <1% | 1,966 | $23K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 13,279 | $23K |
| 86704 | <1% | 20,574 | $23K | |
| 92551 | <1% | 69,903 | $23K | |
| 86706 | <1% | 24,324 | $23K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 566 | $22K |
| 0072A | <1% | 330 | $22K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 4,741 | $21K |
| 86803 | <1% | 26,724 | $20K | |
| J3490 | Unclassified drugs | <1% | 810 | $20K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 18,670 | $20K |
| 90697 | <1% | 3,722 | $19K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 16,367 | $19K |
| 59430 | <1% | 1,190 | $18K | |
| 96156 | <1% | 15,209 | $18K | |
| 97162 | <1% | 12,379 | $18K | |
| 90847 | Family psychotherapy with the patient present, 50 minutes | <1% | 1,898 | $18K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 35,514 | $18K |
| G9920 | Screening performed and negative | <1% | 2,286 | $15K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 174,674 | $15K |
| 0154A | <1% | 281 | $14K | |
| 90686 | <1% | 51,795 | $14K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 5,149 | $14K |
| 86592 | <1% | 50,354 | $13K | |
| 87210 | <1% | 29,046 | $12K | |
| 90750 | <1% | 3,347 | $12K | |
| 82951 | <1% | 11,561 | $12K | |
| 90853 | Group psychotherapy (other than of a multiple-family group) | <1% | 2,329 | $12K |
| 99221 | <1% | 328 | $11K | |
| 90670 | <1% | 13,937 | $11K | |
| 92083 | <1% | 1,284 | $11K | |
| 99402 | <1% | 5,949 | $11K | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 380 | $11K |
| 97039 | <1% | 2,492 | $10K | |
| 90661 | <1% | 4,736 | $10K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 17,208 | $10K |
| 90710 | <1% | 3,580 | $10K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 16,435 | $9K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 651 | $9K |
| 0081A | <1% | 184 | $9K | |
| 83550 | <1% | 10,502 | $8K | |
| 84153 | <1% | 3,651 | $8K | |
| S9445 | Patient education, not otherwise classified, non-physician provider, individual, per session | <1% | 60,598 | $8K |
| 82043 | <1% | 19,042 | $8K | |
| 87522 | Neg quan hep c or qual rna | <1% | 2,242 | $8K |
| 82570 | <1% | 18,391 | $8K | |
| 90715 | <1% | 10,544 | $8K | |
| 83540 | <1% | 11,658 | $7K | |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 1,434 | $7K |
| 92550 | <1% | 1,773 | $7K | |
| 0003A | <1% | 109 | $7K | |
| 11981 | <1% | 122 | $7K | |
| 81015 | <1% | 32,699 | $6K | |
| 90633 | <1% | 9,447 | $6K | |
| 90656 | <1% | 3,577 | $6K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 7,139 | $6K |
| 84439 | <1% | 7,279 | $6K | |
| 87070 | <1% | 16,858 | $5K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 127 | $5K |
| S9452 | Nutrition classes, non-physician provider, per session | <1% | 1,428 | $5K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 38,670 | $5K |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 72 | $5K |
| 92567 | <1% | 2,385 | $5K | |
| 82728 | <1% | 11,512 | $5K | |
| 59025 | Fetal non-stress test | <1% | 1,862 | $5K |
| 90698 | <1% | 5,597 | $5K | |
| 90756 | <1% | 20,122 | $5K | |
| 90619 | <1% | 2,431 | $5K | |
| 85018 | <1% | 49,519 | $4K | |
| 98942 | <1% | 576 | $4K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 414 | $4K |
| 90674 | <1% | 10,700 | $4K | |
| 0073A | <1% | 77 | $4K | |
| T2041 | Supports brokerage, self-directed, waiver; per 15 minutes | <1% | 13 | $4K |
| 92134 | <1% | 969 | $4K | |
| 87340 | <1% | 6,127 | $4K | |
| 84460 | <1% | 14,099 | $4K | |
| 92133 | <1% | 971 | $4K | |
| 86140 | <1% | 6,314 | $4K | |
| 84450 | <1% | 14,096 | $3K | |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 167 | $3K |
| 86708 | <1% | 2,002 | $3K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 20,010 | $3K |
| 96127 | <1% | 32,509 | $3K | |
| 92587 | <1% | 2,158 | $3K | |
| 85651 | <1% | 9,456 | $3K | |
| 11055 | <1% | 290 | $2K | |
| 0082A | <1% | 59 | $2K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 9,338 | $2K |
| 92002 | <1% | 198 | $2K | |
| 90716 | <1% | 1,920 | $2K | |
| 99459 | <1% | 1,263 | $2K | |
| 90680 | <1% | 5,064 | $2K | |
| 97811 | <1% | 340 | $2K | |
| H2000 | Comprehensive multidisciplinary evaluation | <1% | 311 | $2K |
| 0173A | <1% | 56 | $2K | |
| 83735 | <1% | 2,112 | $2K | |
| 58300 | <1% | 201 | $2K | |
| 90480 | <1% | 830 | $2K | |
| 87081 | <1% | 4,448 | $2K | |
| 81003 | <1% | 26,420 | $2K | |
| 90381 | <1% | 177 | $2K | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 1,931 | $2K |
| 90734 | <1% | 3,506 | $2K | |
| 83970 | <1% | 39 | $2K | |
| 97001 | <1% | 46 | $2K | |
| 83690 | <1% | 1,825 | $1K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 917 | $1K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 5,968 | $1K |
| 31575 | <1% | 144 | $1K | |
| 90632 | <1% | 340 | $1K | |
| 96112 | <1% | 89 | $1K | |
| 11982 | <1% | 24 | $1K | |
| 90681 | <1% | 634 | $1K | |
| 81001 | <1% | 8,207 | $1K | |
| 90696 | <1% | 2,303 | $1K | |
| 99412 | <1% | 79 | $1K | |
| 90636 | <1% | 251 | $1K | |
| 84702 | <1% | 709 | $1K | |
| 84550 | <1% | 1,962 | $1K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 1,010 | $973.02 |
| 86593 | <1% | 1,155 | $920.52 | |
| 80076 | <1% | 1,811 | $903.98 | |
| 99234 | <1% | 12 | $896.40 | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 193 | $885.34 |
| H1000 | Prenatal care, at-risk assessment | <1% | 57 | $880.10 |
| 85027 | <1% | 1,749 | $804.46 | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 60 | $793.05 |
| 99188 | <1% | 439 | $738.00 | |
| 80074 | <1% | 108 | $719.29 | |
| 90707 | <1% | 1,423 | $703.85 | |
| 20610 | <1% | 1,187 | $693.91 | |
| 91321 | <1% | 376 | $685.80 | |
| 83921 | <1% | 32 | $678.72 | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 2,454 | $652.75 |
| 82947 | <1% | 10,674 | $635.95 | |
| 86769 | <1% | 344 | $631.95 | |
| 80081 | <1% | 334 | $616.79 | |
| 90688 | <1% | 2,427 | $580.00 | |
| 99283 | Emergency room visit (moderate) | <1% | 13 | $579.80 |
| 99201 | <1% | 683 | $572.50 | |
| 82607 | <1% | 172 | $571.64 | |
| 90685 | <1% | 772 | $560.00 | |
| 84156 | <1% | 777 | $554.27 | |
| 85610 | <1% | 4,201 | $550.08 | |
| 97164 | <1% | 60 | $538.23 | |
| 90700 | <1% | 2,331 | $515.57 | |
| 11056 | <1% | 69 | $512.75 | |
| 99000 | <1% | 70,213 | $488.51 | |
| 90713 | <1% | 535 | $474.60 | |
| 90744 | <1% | 3,661 | $446.66 | |
| 90746 | <1% | 784 | $439.89 | |
| 98926 | <1% | 33 | $395.40 | |
| 82565 | <1% | 855 | $385.63 | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 3,289 | $361.20 |
| G0466 | Community health center visit, new patient | <1% | 49 | $334.50 |
| 90694 | <1% | 379 | $323.91 | |
| 90785 | <1% | 730 | $316.74 | |
| 96151 | <1% | 1,319 | $302.76 | |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | <1% | 2,862 | $297.46 |
| 92100 | <1% | 66 | $289.33 | |
| 82747 | <1% | 16 | $282.40 | |
| 99385 | <1% | 134 | $276.00 | |
| 85014 | <1% | 1,268 | $269.67 | |
| 99453 | <1% | 15 | $266.55 | |
| 92132 | <1% | 25 | $247.99 | |
| 11730 | <1% | 92 | $224.14 | |
| 90648 | <1% | 1,468 | $212.50 | |
| L3260 | Surgical boot/shoe, each | <1% | 67 | $199.65 |
| 90714 | <1% | 253 | $199.31 | |
| 83721 | <1% | 177 | $194.52 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 171 | $192.00 |
| 82310 | <1% | 217 | $186.87 | |
| 87209 | <1% | 13 | $163.35 | |
| 80354 | <1% | 2,649 | $161.61 | |
| 86701 | <1% | 152 | $151.09 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 4,837 | $150.36 |
| 90461 | <1% | 19,824 | $146.34 | |
| 82248 | <1% | 564 | $146.14 | |
| 84132 | <1% | 234 | $142.96 | |
| 76514 | <1% | 33 | $137.48 | |
| 82247 | <1% | 691 | $135.90 | |
| 99406 | <1% | 2,687 | $117.84 | |
| 97010 | <1% | 109 | $115.68 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,296 | $112.10 |
| 90653 | <1% | 193 | $106.00 | |
| 82270 | <1% | 365 | $105.12 | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 41,383 | $104.72 |
| 96160 | <1% | 41,011 | $103.05 | |
| 99070 | <1% | 722 | $102.96 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 1,141 | $102.85 |
| G0071 | Payment for communication technology-based services for 5 minutes or more of a virtual (non-face-to-face) communication between an rural health clinic (rhc) or federally qualified health center (fqhc) practitioner and rhc or fqhc patient, or 5 minutes or more of remote evaluation of recorded video and/or images by an rhc or fqhc practitioner, occurring in lieu of an office visit; rhc or fqhc only | <1% | 18 | $102.84 |
| 99417 | Prolong home eval add 15m | <1% | 27 | $85.14 |
| 84100 | <1% | 68 | $73.48 | |
| 80055 | <1% | 141 | $70.94 | |
| 96150 | <1% | 1,850 | $67.29 | |
| 96113 | <1% | 26 | $63.22 | |
| 20611 | <1% | 70 | $55.52 | |
| 86580 | <1% | 3,802 | $50.35 | |
| 87329 | <1% | 14 | $49.68 | |
| G0109 | Diabetes outpatient self-management training services, group session (2 or more), per 30 minutes | <1% | 80 | $49.04 |
| 86787 | <1% | 47 | $48.84 | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 65 | $44.52 |
| 91200 | <1% | 332 | $41.83 | |
| 69209 | <1% | 1,001 | $41.37 | |
| 82746 | <1% | 42 | $40.04 | |
| 92020 | <1% | 12 | $38.42 | |
| A9300 | Exercise equipment | <1% | 271 | $37.50 |
| 36415 | Collection of venous blood by venipuncture | <1% | 10,336 | $31.50 |
| 94760 | <1% | 22,365 | $29.33 | |
| 99173 | <1% | 51,144 | $25.44 | |
| G0511 | Rural health clinic or federally qualified health center (rhc or fqhc) only, general care management, 20 minutes or more of clinical staff time for chronic care management services or behavioral health integration services directed by an rhc or fqhc practitioner (physician, np, pa, or cnm), per calendar month | <1% | 29 | $24.40 |
| H0001 | Alcohol and/or drug assessment | <1% | 3,431 | $22.50 |
| 86308 | <1% | 26 | $22.41 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,299 | $18.50 |
| 96152 | <1% | 166 | $16.82 | |
| A4267 | Contraceptive supply, condom, male, each | <1% | 296 | $16.20 |
| S5199 | Personal care item, nos, each | <1% | 12 | $3.20 |
| 85007 | <1% | 894 | $2.71 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 375 | $1.09 |
| 3079F | 0% | 66,635 | $0.00 | |
| 3074F | 0% | 306,413 | $0.00 | |
| 3008F | 0% | 49,084 | $0.00 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 47,138 | $0.00 |
| 3075F | 0% | 21,349 | $0.00 | |
| Z6406 | 0% | 4,254 | $0.00 | |
| 3044F | 0% | 4,838 | $0.00 | |
| Z1034 | 0% | 25,010 | $0.00 | |
| Z6410 | 0% | 2,749 | $0.00 | |
| 99381 | 0% | 2,662 | $0.00 | |
| 36416 | 0% | 1,559 | $0.00 | |
| 2023F | 0% | 2,684 | $0.00 | |
| 90732 | 0% | 247 | $0.00 | |
| Z1038 | 0% | 928 | $0.00 | |
| 96161 | 0% | 210 | $0.00 | |
| Z6402 | 0% | 2,154 | $0.00 | |
| Z6204 | 0% | 4,792 | $0.00 | |
| 99243 | 0% | 13 | $0.00 | |
| X3924 | 0% | 626 | $0.00 | |
| 3080F | 0% | 973 | $0.00 | |
| 0011A | 0% | 464 | $0.00 | |
| 99383 | 0% | 105 | $0.00 | |
| X4102 | 0% | 110 | $0.00 | |
| X4304 | 0% | 5,536 | $0.00 | |
| Z1032 | 0% | 2,144 | $0.00 | |
| 97804 | 0% | 72 | $0.00 | |
| V2103 | Spherocylinder, single vision, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens | 0% | 322 | $0.00 |
| A4627 | Spacer, bag or reservoir, with or without mask, for use with metered dose inhaler | 0% | 13 | $0.00 |
| X4100 | 0% | 113 | $0.00 | |
| 99024 | 0% | 105 | $0.00 | |
| 91307 | 0% | 50 | $0.00 | |
| 91301 | 0% | 254 | $0.00 | |
| Z6404 | 0% | 189 | $0.00 | |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | 0% | 290 | $0.00 |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 0% | 43 | $0.00 |
| 58100 | 0% | 138 | $0.00 | |
| 3072F | 0% | 207 | $0.00 | |
| 0012A | 0% | 76 | $0.00 | |
| 1038F | 0% | 13 | $0.00 | |
| 99384 | 0% | 74 | $0.00 | |
| 57454 | 0% | 25 | $0.00 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 88 | $0.00 |
| V2104 | Spherocylinder, single vision, plano to plus or minus 4.00d sphere, 2.12 to 4.00d cylinder, per lens | 0% | 38 | $0.00 |
| 86850 | 0% | 19 | $0.00 | |
| V2100 | Sphere, single vision, plano to plus or minus 4.00, per lens | 0% | 75 | $0.00 |
| J7644 | Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | 0% | 85 | $0.00 |
| 87088 | 0% | 77 | $0.00 | |
| 31231 | 0% | 27 | $0.00 | |
| 91317 | 0% | 51 | $0.00 | |
| L1810 | Knee orthosis, elastic with joints, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise | 0% | 13 | $0.00 |
| 0031A | 0% | 72 | $0.00 | |
| 90474 | 0% | 54 | $0.00 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 0% | 45 | $0.00 |
| 80050 | General health panel | 0% | 142 | $0.00 |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 0% | 13 | $0.00 |
| 58301 | 0% | 26 | $0.00 | |
| S8101 | Holding chamber or spacer for use with an inhaler or nebulizer; with mask | 0% | 12 | $0.00 |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | 0% | 49 | $0.00 |
| 83001 | 0% | 13 | $0.00 | |
| 91315 | 0% | 13 | $0.00 | |
| 91303 | 0% | 25 | $0.00 | |
| 99441 | 0% | 16 | $0.00 | |
| 2022F | 0% | 915 | $0.00 | |
| 3078F | 0% | 280,159 | $0.00 | |
| X3904 | 0% | 3,299 | $0.00 | |
| Z6304 | 0% | 3,533 | $0.00 | |
| 3077F | 0% | 7,032 | $0.00 | |
| 86677 | 0% | 148 | $0.00 | |
| Z6400 | 0% | 10,912 | $0.00 | |
| Z6300 | 0% | 2,218 | $0.00 | |
| Z6308 | 0% | 775 | $0.00 | |
| 2028F | 0% | 2,100 | $0.00 | |
| T1013 | Sign language or oral interpretive services, per 15 minutes | 0% | 6,907 | $0.00 |
| 92582 | 0% | 977 | $0.00 | |
| 91312 | 0% | 701 | $0.00 | |
| 92553 | 0% | 2,732 | $0.00 | |
| 87186 | 0% | 77 | $0.00 | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 0% | 721 | $0.00 |
| Q0144 | Azithromycin dihydrate, oral, capsules/powder, 1 gram | 0% | 210 | $0.00 |
| 90658 | 0% | 83 | $0.00 | |
| Z6500 | 0% | 88 | $0.00 | |
| Z6414 | 0% | 1,527 | $0.00 | |
| 90380 | 0% | 183 | $0.00 | |
| 91308 | 0% | 104 | $0.00 | |
| Z6200 | 0% | 1,695 | $0.00 | |
| H0005 | Alcohol and/or drug services; group counseling by a clinician | 0% | 450 | $0.00 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 0% | 137 | $0.00 |
| Z6208 | 0% | 1,034 | $0.00 | |
| X4110 | 0% | 4,557 | $0.00 | |
| 92555 | 0% | 566 | $0.00 | |
| 10060 | 0% | 195 | $0.00 | |
| 84403 | 0% | 84 | $0.00 | |
| 90611 | 0% | 147 | $0.00 | |
| 96159 | 0% | 153 | $0.00 | |
| X4301 | 0% | 313 | $0.00 | |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | 0% | 163 | $0.00 |
| 92579 | 0% | 919 | $0.00 | |
| 82465 | 0% | 173 | $0.00 | |
| 0110T | 0% | 201 | $0.00 | |
| 90630 | 0% | 370 | $0.00 | |
| 91313 | 0% | 99 | $0.00 | |
| 90473 | 0% | 240 | $0.00 | |
| 76981 | 0% | 15 | $0.00 | |
| Z6302 | 0% | 102 | $0.00 | |
| 83718 | 0% | 159 | $0.00 | |
| 84146 | 0% | 40 | $0.00 | |
| 96116 | 0% | 15 | $0.00 | |
| 90687 | 0% | 94 | $0.00 | |
| 99382 | 0% | 38 | $0.00 | |
| 91300 | 0% | 12 | $0.00 | |
| 91322 | 0% | 139 | $0.00 | |
| 92552 | 0% | 56 | $0.00 | |
| 96158 | 0% | 44 | $0.00 | |
| 96167 | 0% | 31 | $0.00 | |
| 0013A | 0% | 14 | $0.00 | |
| L1812 | Knee orthosis, elastic with joints, prefabricated, off-the-shelf | 0% | 12 | $0.00 |
| L1836 | Knee orthosis, rigid, without joint(s), includes soft interface material, prefabricated, off-the-shelf | 0% | 12 | $0.00 |
| Z6202 | 0% | 42 | $0.00 | |
| 99411 | 0% | 13 | $0.00 | |
| 94060 | 0% | 13 | $0.00 | |
| 80305 | 0% | 12 | $0.00 | |
| V2203 | Spherocylinder, bifocal, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens | 0% | 12 | $0.00 |
| J7510 | Prednisolone oral, per 5 mg | 0% | 18 | $0.00 |
| J7614 | Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg | 0% | 21 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.